Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Income from Non-Controlling Interests (2020 - 2025)

P3 Health Partners (PIII) has disclosed Income from Non-Controlling Interests for 6 consecutive years, with -$37.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Non-Controlling Interests rose 32.77% year-over-year to -$37.9 million, compared with a TTM value of -$174.5 million through Sep 2025, down 36.31%, and an annual FY2024 reading of -$174.5 million, down 35.66% over the prior year.
  • Income from Non-Controlling Interests was -$37.9 million for Q3 2025 at P3 Health Partners, down from -$23.3 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $3.3 million in Q1 2021 and bottomed at -$748.8 million in Q2 2022.
  • Average Income from Non-Controlling Interests over 5 years is -$96.9 million, with a median of -$30.9 million recorded in 2024.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 38313.13% in 2022, then soared 97.63% in 2023.
  • Year by year, Income from Non-Controlling Interests stood at $2.8 million in 2021, then plummeted by 15742.77% to -$438.3 million in 2022, then surged by 94.53% to -$24.0 million in 2023, then plummeted by 273.11% to -$89.5 million in 2024, then skyrocketed by 57.69% to -$37.9 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for PIII at -$37.9 million in Q3 2025, -$23.3 million in Q2 2025, and -$23.8 million in Q1 2025.